Gyroscope Therapeutics Holdings plc IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Gyroscope Therapeutics Holdings plc | VISN - NASDAQ |
Postponed | $0.00 | $0.00 | Postponed | 5/7/2021 |
| Morgan Stanley, Goldman Sachs, Citigroup | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-04-16 Terms Added 2021-05-03 | ||||||
About Gyroscope Therapeutics Holdings plc (adapted from Gyroscope Therapeutics Holdings plc prospectus):
They are a global clinical-stage gene therapy company developing gene therapy beyond rare diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a global clinical-stage gene therapy company developing gene therapy beyond rare diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "VISN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.